TENIDAP (TD) was initially defined as a dual inhibitor of cyclooxygenase and lipoxygenase. This study was designed to assess its inhibitory activity against proinflammatory phosphoHpase A 2. This study shows that TD inhibits the synthesis of pro-inflammatory secretory non-pancreatic phospholipase A (sPLA2). Concentrations as low as 0.251lg/ml (0.725 JIM) reduced the release of sPLA by 40% from foetal rat calvarial osteoblasts stimulated with IL-I and TNF, whereas a concentration of 2.5 tg/ml (7.25 IIM) reduced the release by over 800/0. TD also markedly reduced the release of sPLA from unstimulated cells. There was no direct inhibition of sPLA enzymatic activity by TD in vitro. Northern blot analysis showed that TD did not affect the sPLA mRNA levels; however, immunoblotting showed a dose-dependent reduction in sPLA enzyme. These results, together with a marked reduction in sPLA enzymatic activity, suggest that TD inhibits sPLA synthesis at the post-transcriptional level. Therefore TD seems to inhibit the arachidonic acid cascade proximally to cyclooxygenase and ltpoxygenase and its anti-inflammatory activity may be related at least in part to the inhibition of sPLA synthesis.
1," It soon became apparent that TD had other biological properties such as inhibition of IL-1 production in LPS-stimulated cells, 3, 4 inhibition of the release and/or activity of collagenase and myeloperoxidase and suppression of the expression of circulating acute phase reactants such as serum amyloid A in rheumatoid patients treated with TD and of C-reactive protein in rats with adjuvant arthritis. TD also inhibits bone resorption induced by cytokines IL-1 and TNF. Since 12 The probe used for hybridization was the rat sPLA cDNA. 13 The DNA fragment was labelled by random priming (Pharmacia) and prehybridization was done in a 50% formamide buffer at 42C. The blot was washed in lx55C 0.5% SDS at 50C and exposed to Kodak XARfilm at-80C with an intensifying screen.
Western blot analysis: SDS-polyacrylamide gel electrophoresis was done on 12% polyacrylamide gels using the method of Laemmli.
14 Proteins were then electrophoretically transferred to nitrocellulose (Hybond*M-ECL, Amersham Canada, Ltd) 5 for immunoblot analysis, The primary antibody was a rat sPLA monoclonal antibody (mAb 2E7 plus 2B9). 16 The blot was developed using enhanced chemiluminescence (ECL) as described by the manufacturer (ECL TM Western blotting protocols, Amersham International plc). (Fig. 1) . TD in concentrations over 1.25 l.tg/ml was slightly inhibitory to cell proliferation, reducing the final number of cells from 0.92 + 0.02 x 10/ml in controls to 0.78 + 0.02 x 10/ml; concentrations over 2.5 g/ml reduced final cell counts to 0.63 + 0.03xl0/ml.
Northern blot analysis of FRCO total RNA showed that TD at 1.25 t.tg/ml did not affect the level of sPLA mRNA in unstirnulated or IL-1/TNF stimulated cells (Fig. 2) . In contrast, immunoblot analysis revealed reduction in the quantity of sPLA in FRCO treated with 0.25 btg/ml (0.725 btM) TD (Fig. 3) . At the TD concentration of 3.75 btg/ml (10.875 18 The IC50 of TD for cyclooxygenase and lipoxygenase was 0.05 t-tM and 10 btM respectively. When whole blood was used, TD did not suppress 5-1ipoxygenase at all. It was therefore concluded that, in vivo, TD is essentially a selective inhibitor of cyclooxygenase. 18 Subsequent studies of TD have detected its impact on cytokine production. Endotoxin-induced IL-1 synthesis in murine peritoneal macrophages was markedly inhibited by TD (IC50 1 btg/ml). Subcellular studies identified the block of pro-IL-lot in the cells.
Higher concentrations of TD (10 btg/ml) also inhibited IL-1 activity in LPS-stimulated human monocytes 19 and production of and 41, 42 Thus, inhibition of sPLA synthesis by TD seems to be an important part of this general effect on cell metabolism. TD had no direct effect on PEA enzymatic activity.
The fact that TD inhibits the synthesis of sPLA adds to the repertoire of its biological activities and shows that this agent may inhibit the arachidonic acid cascade, at a level proximal, to that of cyclooxygenase and lipoxygenase. Marked inhibition of sPLA synthesis by TD may be partially responsible for its anti-inflammatory activity.
